Background: Taraxacum officinale (L.) Weber (Asteraceae) has been extensively employed as a diuretic in traditional folk medicine and in modern phytotherapy in Europe, Asia, and the Americas without prior clinical trial substantiation.
Introduction
U se of medicinal plants is increasingly popular in the United States and Europe, and out of economic necessity, continues to be so in developing countries. In some cases, extracts of medicinal plants are used by traditional healers as diuretics. 1 A review by Dearing et al. 2 reports that 85 species of plants from diverse families have demonstrated evidence of diuretic activity. After reviewing the available literature on medicinal plants used to induced diuresis, Yarnell 1 suggests that a number of different botanical medicines show promise in the treatment of a variety of urologic disorders. Additionally, the Commission E approves at least 12 plant extracts as diuretics. Although there are human trials to support or refute the use of traditional remedies as diuretics, they are few and thus, there is a significant void in research to reveal the value of the majority of these remedies.
Species of Taraxacum have been employed as a diuretic for over 2000 years in both Traditional Chinese Medicine and in Ayurvedic medicine. [3] [4] [5] The species found in most U.S. and European herbal remedies is Taraxacum officinale (L.) Weber (Asteraceae), commonly known as dandelion, Herba Taraxaci, or Taraxacum herba. It is used ubiquitously as a remedy in a variety of conditions. Even before publication in Elizabeth Blackwell's Curious Herbal in 1734, the use of dandelion leaf as a diuretic persisted across cultural and temporal barriers. In French, dandelion is known as pissenlit, a colorful description of its diuretic activity. These ethnobotanical and historical data suggest that various species of dandelion have been widely employed for urinary and renal diseases to enhance the renal elimination of fluids. As suggested by Mills* when societies socially and geographically distant from one another find common uses for the same genera, this provides empirical evidence of a medicinal plant's pharmacological activity.
Currently, clinicians using phytotherapy make use of dandelion leaf in various preparations including infusions, ethanolic extracts, or fresh expressed juice where ''enhanced urinary output is desirable.'' 6 Supporting this indication the German Standard License for dandelion tea includes stimulation of diuresis, and the German Commission E approves the use of dandelion for diuresis. 7, 8 Rácz-Kotilla et al. 9 quantified the diuretic activity in a murine model, reporting that the leaf of dandelion, a better diuretic and saluretic than the root, was comparable to furosemide (Lasix at 80 mg=kg). Despite consistent traditional use, a recent review article by Schutz et al. 10 discusses the mixed results and scant data of the pharmacological research characterizing dandelion's utility as a diuretic.
Besides its diuretic utility, dandelion is added to salads perhaps due to its rich nutrient content. 11 Dandelion is a significant source of potassium, as well as other vitamins and minerals. 12 Reported potassium levels have ranged from 23.3 mg=g 13 to 59.9 mg=g, 14 with median figures of 42.5 mg=g 9 and 45.1 mg=g 15 of dried leaf. Rácz-Kotilla et al. 9 conclude that dandelion contains three times the amount of potassium in other botanical diuretics and provides more potassium than that lost from diuresis induced by ingesting dandelion. Considering the requirement for potassium supplementation that typically accompanies the use of a pharmaceutical diuretic, dandelion could offer a therapeutically significant potassium contribution by replacing the potassium loss induced by most diuretics.
In spite of a high safety rating, to date there are no published human studies on extracts of T. officinale. 16 Given the extensive traditional use of dandelion and its observed therapeutic activity, the objective of this pilot study was to investigate whether ingestion of a high-quality ethanolic extract of dandelion folium results in an increased urinary frequency and volume.
Methodology

Design
This study was conducted over a period of 4 days at the Tai Sophia Institute in Laurel, MD, with a group of healthy female subjects aged 18-65. Conducted under Tai Sophia Institute's IRB approval, it was performed according to the guidelines of the Declaration of Helsinki and Tokyo for humans, and was performed only after informed consent was obtained. Subjects were instructed to abstain from consumption of alcohol and to practice daily consistency with any medications and caffeinated beverages.
Materials
The dandelion ethanolic extract used in the interventions was from a single organically grown batch (Oregon Tilth) and extracted by Oregon's Wild Harvest (Sandy, OR). Botanical identity was confirmed by thin layer chromatography ( Fig. 1 ) and a Certificate of Analysis, both provided by the manufacturer. The concentration of the tincture was 1 g to 1 mL of menstruum (95% EtOH). The water content of the leaf, measured by weight of dehydrated herb, was 87%. The manufacturer reports a calculated ethanol content of 43.5% in the final extract.
Measuring devices
Participants were supplied and educated in the use of two measurement devices. For the collection and determination of urine, study participants were supplied with a single graduated 600-mL Disposa-Beaker. The participants also received a device for measuring their dosage of the dandelion extract, with graduations of 1 mL up to 10 mL.
Procedure
Participants attended an information session where they were informed of the details and potential adverse events of the study. Upon signing the consent form, they were given the materials for the study. Twenty-eight (28) people volunteered to participate in the study and signed the consent form. The mean age of participants was 37.9 years.
Subjects monitored their fluid intake for 4 consecutive days. The subjects also recorded their urine output for 3 consecutive days starting on the second day (day À1). Subjects self-administered a measured 8-mL dose of dandelion leaf extract at 8:00 am, 1:00 pm, and 6:00 pm on the study day (day 0). After the follow-up day (day 1), participants returned the data sheets for analysis. Eleven (11) participants were unable to complete the study, citing difficulty collecting and measuring of fluid output and=or input. Concurrent medication use was limited to 3 subjects; 1 subject reported medication for asthma and 2 subjects reported oral contraceptive use.
Trial outline
The outline for the 4-day trial is summarized in Table 1 , with the consumption of alcoholic and caffeinated beverages restricted throughout the trial. 
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Safety measures
Participants were given a phone number that had direct access to the principal investigator and were advised to contact this individual should any adverse events occur. No adverse events were recorded.
Statistics
All data were recorded on standardized forms. Data analysis was performed on both the frequency of urination and the ratio of fluid output to intake volume (excretion ratio). Data are expressed as the mean AE standard error of the mean and significance was determined using paired or unpaired t-tests as appropriate. The first day of full data collection (day À1) was used as the control day, and the subsequent treatment day (day 0) and the follow-up day (day 1) were analyzed in comparison to that day. Data were analyzed in 5-hour blocks, aligned with the administration times of 8:00 am, 1:00 pm, and 6:00 pm. Five (5)-hour time periods were chosen to resolve the purported fast onset of a diuretic effect without compromising the daily lifestyle of the subjects. The mean values were considered significantly different if p < 0.05.
Results
Frequency of urination
The mean daily frequency of urination for the entire population (n ¼ 17) on the control day (day À1) was 8.0 AE 0.76. This increased to 9.0 AE 0.93 on the day of the trial (day 0) and decreased on the day after the trial to 8.1 AE 1.1 (day 1). By pairwise comparison, there is a significant (p < 0.05) increase in the frequency of urination for the study group on the day of the trial. Figure 2 plots the average frequency of urination per subject broken down into 5-hour periods throughout the day, on the day before, the day of, and the day after the trial. There was a significant increase (p < 0.05) in the frequency on the day of the trial from 8:00 am to 1:00 pm, coinciding with the first dose. A smaller increase (p < 0.1) was observed coinciding with the second dose.
Excretion ratio
For the study group, the mean fluid intake (output) per subject on the control day was 2125 AE 188 mL (1874 AE 221 mL), increasing to 2313 AE 249 mL (2148 AE 212 mL) on the day of the trial and decreasing to 1998 AE 153 mL (1988 AE 205 mL) on day 1. From these statistics, there was no signif-icant difference in either the volume of fluids consumed or excreted on a daily basis during the trial. Figure 3 shows the average excretion ratio for all subjects per 5-hour period. Between 1:00 pm and 6:00 pm on the study day (day 0), there was a significant increase (p < 0.001) in the average excretion ratio compared to the control day, primarily due to both an increase in the urination volume per visit (p < 0.1), decrease in fluid intake (p < 0.1) and increase in frequency (p < 0.1).
Discussion
The limitations of this study design include lack of blinding, small numbers of subjects, self-monitoring for fluid input= output, no correction for water content of food consumed, and limited baseline values of urine output. A double-blind placebo-controlled trial with larger numbers of subjects, coupled with more objective measurements of the active diuretic compounds in dandelion and fluid output and input, would facilitate further evaluation of the diuretic effects of dandelion leaf extracts and is planned for future investigations. Despite these limitations, the data presented in this pilot study, which mimics actual use of dandelion by those using herbal remedies, offers insight into the diuretic activity of a dandelion ethanolic extract.
There was a significant increase in urination frequency (p < 0.05) demonstrated by trial subjects after administration of the extract. The excretion ratio also increased (p < 0.001). In particular, the 5-hour period after the first dose had a significant increase in frequency and following a second dose, in the second 5-hour period, there was a significant increase in the excretion ratio. However, after a third dose (evening dose), there were no significant changes in fluid intake, urination, or frequency.
The lack of effect observed in the last dose of the day may relate to circadian shifts in kidney function. Due to decrease of solute diuresis (e.g., urea, sodium, and potassium) and Table 1 . Outline for the 4-Day Trial
Day À2
Restriction on type of fluid intake, record fluid intake Day À1
Restriction on type of fluid intake, record fluid intake, record urine output Day 0
Restriction on type of fluid intake, take Taraxacum extract at 8:00 am, 1:00 pm, and 6:00 pm, record fluid intake, record urine output Day 1
Restriction on type of fluid intake, record of fluid intake, record urine output nocturnal decrease in fluid intake, nocturnal urinary volume is lower than that of daytime hours. 17 Another factor limiting nocturnal urinary volume is the increase in urine concentration due to increased vasopressin secretion=activity. 18 Healthy subjects demonstrate a urinary output that is three times the nocturnal output 18 and show the average rate of urinary production at night is less than half of that produced during daytime hours. 19 These results suggest that dandelion leaf may be fast acting and rapidly cleared. However, these results do not rule out that dandelion leaf acts as a bladder irritant due to the increase in the daily frequency but not the daily urination volume. Other investigations utilizing murine models have failed to find increases in daily urination volume. Tita et al. 20 observed no diuresis over 2 hours after a single unspecified dose. Hook et al., 15 also using a single dose over a few hours, observed a saluresis, but not diuresis. In contrast, the results from Rácz-Kotilla et al. 9 demonstrate a diuretic effect at the human equivalent dose (HED) of 640 mg=kg. It should be noted that the dosing used in the present study was over 22 times lower than the optimal diuretic dose used in Rácz-Kotilla's investigation and over 82 times lower than the dose inducing acute toxicity (HED ¼ 2.3 g=kg). 9 Considering the strength of these data, a higher dose in capsule form would facilitate a placebo control and perhaps more clearly elucidate the effect of dandelion on diuresis. An unfortunate consequence of pharmaceutical diuretic therapies may be oxidative damage to the kidneys resulting from glucose intolerance 2 and electrolyte and acid-base disorders. 21 Diuretics such as furosemide and hydrochlorothiazide with choline substituents in their molecular structure, may also lead to free-radical reactions within multiple tissue compartments. 22 A substantial portion of these detrimental effects are the result of hypokalemia, as well as hypomagnesemia. Although magnesium depletion is a less recognized effect of pharmaceutical diuretics, as many as 40% of those on diuretic therapy who develop hypokalemia may also have hypomagnesemia. 23 In addition, hypokalemia may be refractory to potassium supplementation unless magnesium is adequately repleted. 24 As a result of these detrimental effects, many diuretics may be harmful with long-term use. [25] [26] [27] [28] Considering the mineral content and the antioxidant activity of dandelion, an interesting possibility is utilizing dandelion as an adjuvant with pharmaceutical diuretics. Given that the combination of potassium and magnesium in supplement form have been shown to be equally as effective as KCl, 29 it may be that the mineral content of dandelion leaf with potassium at &42.5 mg=g 9 and magnesium at &2.5 mg=g 13, 14 may mitigate some of the electrolyte imbalance resulting from pharmaceutical diuretic use. Animal models have demonstrated that supplementation of dandelion leaf results in elimination of less potassium and magnesium than that contained in extracts of dandelion. 30 In considering the tissue damage induced by oxidative stress from pharmaceutical diuretic use, adjuvant use of dandelion extracts, shown to have substantial antioxidant activity, could be advantageous. Antioxidant activity has been observed in a number of different models. 3, 31, 32 Sumanth and Rana 33 reported increases in the levels of superoxide dismutase, catalase, and glutathione using an ethanolic preparation of dandelion. Zhu et al, 32 also using an ethanolic extract, confirmed Rana's results finding superoxide dismutase, catalase, and glutathione levels increased along with peroxidase levels, and also found reduced lipid peroxidation. Hu and Kitts 3 demonstrated protection of cells from peroxylradical-induced intracellular oxidation, speculating that the protection may have been the result of scavenging of intercellular and intracellular peroxyl radicals by a phenolic-rich extract from dandelion flowers. This group also showed a synergic effect with a-tocopherol and a 40% ascorbate equivalence, which they believed was responsible for regenerating the a-tocopherol.
Many of the complications of pharmaceutical diuretics may be mitigated by proper dosage and replacement of electrolyte losses. 2 Accordingly, combination of a dandelion extract with a pharmaceutical diuretic should be investigated. Possible outcomes include reduced dosage require- ments of the pharmaceutical diuretic, improved diuresis, decreased oxidative kidney damage and decreased need for potassium and magnesium supplementation. Of the half dozen modes of activity through which diuretics increase the flow of urine, the most efficacious pharmaceutical diuretics act through a single route referred to as ''loop diuresis''-affecting sodium reabsorption in the loop of Henle. 34 Of the eight drugs classified as loop diuretics, there is little chemical structural similarity or functional group commonalities between them. Similarly, diuretic compounds found in plants may be due to several constituent groups of secondary metabolites such as terpenes, phenolics, or alkaloids. 34 Of interest is the number of secondary metabolites in dandelion that are diuretic. According to Duke's USDA database, 35 dandelion has up to nine compounds that are diuretic ( Table 2 ). Given that the saluretic effects of dandelion leaf have been shown to be due to multiple fractions of the extract, 15 the diuretic activity of dandelion may be due to several compounds via different diuretic and saluretic pathways. Considering that these active constituents have many other beneficial effects (Table 2) , including favorable cardiovascular activity, further research is needed on dandelion leaf's potential therapeutic role.
Conclusions
The data from this human trial demonstrate that an ethanolic extract of T. officinale fresh leaf (1 g:1 mL), increases the frequency and excretion ratio of fluids in healthy human subjects. These results suggest further detailed investigations are warranted.
